{"schema_version":"secwatch.filing_event.v1","accession":"0001387131-23-009019","form_type":"8-K","ticker":"TNXP","cik":"0001430306","company_name":"Tonix Pharmaceuticals Holding Corp.","filed_at":"2023-07-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.903376+00:00","generated_at":"2026-06-12T22:54:54.434696+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Tonix prices $7M public offering of common stock and warrants to fund operations","bullets":["Priced $7M public offering: 2.53M shares + pre-funded warrants for 4.47M shares + 7M common warrants at $1.00 per unit.","Gross proceeds ~$7M; net proceeds for working capital, facility build-out, and product acquisition/licensing.","Common warrants exercisable at $1.00/share, expire 5 years from issuance.","Lock-up: directors/officers restricted from selling for 60 days post-closing.","Closing expected August 1, 2023; A.G.P. and Brookline Capital Markets acting as placement agents."],"urls":{"canonical":"https://secwatch.observer/filing/0001387131-23-009019","json":"https://secwatch.observer/filing/0001387131-23-009019.json","markdown":"https://secwatch.observer/filing/0001387131-23-009019.md","text":"https://secwatch.observer/filing/0001387131-23-009019.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1430306/000138713123009019/0001387131-23-009019-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1430306/000138713123009019/tnxp_8k-072423.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T22:54:54.434696+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"07baadf4ddc66a035d2dbdf406d65b875a15cde5","claim":"Tonix Pharmaceuticals Holding Corp. entered into Placement Agent Agreement with A.G.P./Alliance Global Partners and Brookline Capital Markets, a division of Arcadia Securities, LLC (the \"Placement Agents\") (effective 2023-07-27).","evidence_excerpt":"On July 27, 2023, the Company also entered into a placement agent agreement (the \"Placement Agent Agreement\") with A.G.P./Alliance Global Partners and Brookline Capital Markets, a division of Arcadia Securities, LLC (the \"Placement Agents\").","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713123009019/0001387131-23-009019-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"A.G.P./Alliance Global Partners and Brookline Capital Markets, a division of Arcadia Securities, LLC (the \"Placement Agents\")"},{"label":"Effective","value":"2023-07-27"}],"fact_type":"material_agreement"},{"claim_id":"c79bcfb822ed49e756c8ad012f2a1bc13e8e4efd","claim":"Tonix Pharmaceuticals Holding Corp. entered into Purchase Agreement with certain institutional investors (the \"Purchasers\") valued at $1.00 (effective 2023-07-27).","evidence_excerpt":"On July 27, 2023, Tonix Pharmaceuticals Holding Corp. (the \"Company\"), entered into a securities purchase agreement (the \"Purchase Agreement\") with certain institutional investors (collectively, the \"Purchasers\").","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713123009019/0001387131-23-009019-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain institutional investors (the \"Purchasers\")"},{"label":"Value","value":"$1.00"},{"label":"Effective","value":"2023-07-27"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}